A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 5, 2012, Pages 833-839

  Rathbun, S W ^a   Aston, C E ^b   Whitsett, T L ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Extremity; Superficial vein thrombosis; Therapy; Thrombophlebitis

Indexed keywords

DALTEPARIN; ENOXAPARIN; IBUPROFEN;

ADULT; AGED; ARTICLE; BLEEDING; BOX PAIN SCALE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FECES COLOR; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; SIDE EFFECT; SUPERFICIAL THROMBOPHLEBITIS; SYMPTOM; THROMBOCYTE COUNT; THROMBUS; TINNITUS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DALTEPARIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; IBUPROFEN; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; OKLAHOMA; PAIN; RISK ASSESSMENT; RISK FACTORS; THROMBOPHLEBITIS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84860431618     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04669.x     Document Type: Article

References (16)

1. Sullivan V, Denk P, Sonnad S, Eagleton M, Wakefield T. Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not Involving the deep venous system. J Am Coll Surg 2001; 193: 556-62.
2. Bounameaux H, Reber-Wasem M. Superficial thrombophlebitis and deep venous thrombosis. Arch Intern Med 1997; 157: 1822-4.
3. Blumenberg R, Barton E, Gelfand M, Skudder P, Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis. J Vasc Surg 1998; 27: 338-43.
4. Belcaro G, Nicolaides A, Errichi B, Cesarone MR, De Sanctis MT, Incandela L, Venniker R. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology 1999; 50: 523-9.
5. Messmore H, Bishop M, Wehrmacher W. Acute venous thrombosis: therapeutic choices for superficial and deep veins. Postgrad Med 1991; 89: 73-7.
6. Husni E, Williams W. Superficial thrombophlebitis of the lower limbs. Surger 1982; 91: 70-4.
7. Lohr J, McDevitt D, Lutter K, Roedersheimer L, Sampson M. Operative management of greater saphenous thrombophlebitis involving the saphenofemoral junction. Am J Surg 1992; 164: 269-75.
8. Chengelis D, Bendick P, Glover J, Brown O, Ranval T. Progression of superficial venous thrombosis to deep vein thrombosis. J Vasc Surg 1996; 24: 745-9.
9. Krause U, Kock J, Kroger K, Albracht K, Rudofsky G. Prevention of deep venous thrombosis associated with superficial thrombophlebitis of the leg by early saphenous vein ligation. Vasa 1998; 27: 34-8.
10. Decousas H. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med 2003; 163: 1657-63.
11. Downing LJ, Strieter RM, Kadell AM, Wilke CA, Greenfield L, Wakefield T. Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg 1998; 28: 848-54.
12. Birdwell B, Raskob G, Whitsett T, Durica SS, Comp PC, George JN, Tytle TL, McKee PA. The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med 1998; 128: 1-7.
13. Prandoni P, Polistena P, Bernardi E, Cogo A, Casara D, Verlato F, Angelini F, Simioni P, Signorini GP, Benedetti L, Girolami A. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 1997; 157: 57-62.
14. Prandoni P, Tormene D, Pesavento R; Vesalio Investigators Group. High vs. low doses of low-molecular weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. J Thromb Haemost 2005; 3: 1152-7.
15. Decousas H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G, Leizorovicz A; CALISTO Study Group. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med 2010; 363: 1222-32.
16. Di Nisio M, Wichers I, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev 2007; CD004982.